Pre-earnings options volume in Iovance Biotherapeutics (IOVA) is 2.2x normal with calls leading puts 8:7. Implied volatility suggests the market is anticipating a move near 12.4%, or 67c, after results are released. Median move over the past eight quarters is 7.6%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics (IOVA) Q4 Earnings Cheat Sheet
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics appoints Kirby as Chief Commercial Officer
- Iovance Biotherapeutics price target lowered to $7.50 from $10 at Piper Sandler
- Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment